The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Ganesh Bio Tech (India) Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shree Ganesh Bio-Tech (India) Ltd has acquired 1,34,58,166 equity shares, equivalent to 5.28% of the voting capital, in Suncare Traders Ltd on March 22, 2026 via open market/off-market deals. The acquirer held no shares in Suncare Traders prior to this transaction, so its stake has moved from 0% to 5.28% in a single purchase. Importantly, the acquirer is not part of the promoter or promoter group of Suncare Traders — it is an external investor. The disclosure was filed under SEBI's Takeover Regulations because the 5% shareholding threshold was crossed. Suncare Traders has a total equity share capital of Rs. 51 crore, comprising 25.5 crore shares of Rs. 2 each.
A new non-promoter shareholder has appeared on the cap table with a 5.28% block, which retail investors should monitor for further stake buildup. Under SEBI's creeping acquisition framework, the acquirer can buy up to 10% without triggering a mandatory open offer, so any additional purchases between 5% and 10% may not require a public offer. The acquirer's identity, intentions, and any follow-on buying could be a key sentiment driver for the stock.